| CAS: | 69207-52-9 | |||||
| 分子式: | C18H34O3 | |||||
| 分子量: | 298.46 | |||||
| 英文名称: |
| |||||
| 用途: | McN3716 是一种肉碱棕榈酰转移酶 I (CPT-1) 抑制剂。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||
| M877772 | MACKLIN | McN3716 | 98% | 5540元/1mg; 12015元/5mg; | 咨询 | ||
储存:2-8℃ 状态:白色到灰白色低熔点固体 | |||||||
| HY-U00159 | MCE | McN3716,69207-52-9,帕莫酸甲酯_MCE(MedChemExpress) | 3950元/1 mg; | 咨询 | |||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 McN3716MCE 国际站:McN3716 品牌:MedChemExpress (MCE) 货号:HY-U00159 CAS 号:69207-52-9 生物活性: McN3716 是一种肉碱棕榈酰转移酶 I (CPT-1) 抑制剂。 体内研究(In Vivo):Inhibition of brain mitochondrial β-oxidation by McN3716 (Methyl palmoxirate, MEP) significantly reduces the levels of all measured HETE and epoxytrienoic acids (EET), nonenzymatic auto-oxidative metabolites of ARA, by 23% to 44% and 32% to 50% compared with vehicle-injected rats, respectively, except for 15-HETE which was unaffected. There is a significant 34% reduction in the level of 6-keto-PGF1α, a byproduct of PGI2 (prostacyclin) in McN3716-treated rats. Similarly, the brain level of hydroxyeicosapentaenoic acids, nonenzymatic auto-oxidative metabolites of EPA, is reduced by 35% to 76% upon McN3716 treatment relative to vehicle[1]. MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:298.46 Formula:C18H34O3 性状:固体 颜色:White to off-white 中文名称:帕莫酸甲酯 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:粉末 -20°C 3年 Animal Administration [1]:Rats[1] Male Sprague Dawley rats are used. The rats receive ad libitum access to standard chow and water. At 15 weeks of age, six rats were subjected to either high-energy, head-focused microwave irradiation or CO2 asphyxiation. A separate group of 11 rats were implanted with a tail vein catheter (intravenous catheter 24 gauge/0.75 inch) and received either an intravenous injection of vehicle or 10 mg/kg of McN3716. Fifteen minutes after injection, rats were rapidly euthanized by high-energy, head-focused microwave irradiation (13.5 kW for 1.6 seconds) to avert ischemia for accurate quantification of in vivo basal levels of nonenzymatic auto-oxidative PUFA metabolites and enzymatically derived metabolites. Previously, we reported that this method reduced β-oxidation of fatty acid by 23% to 74%. McN3716 (Methyl palmoxirate, MEP) readily crosses the blood–brain barrier with a plasma half-life of 0.6 minute in the rat. The brain was excised and stored at -80°C for lipidomics profiling. MCE尚未独立确认这些方法的准确性。 仅供参考。 文献引用:MCE 顾客使用本产品发表 1 篇科研文献 提供质量检测报告:Data Sheet、SDS、COA、HNMR、MS、GC、产品使用指南 产品活性:McN3716 是一种肉碱棕榈酰转移酶 I (CPT-1) 抑制剂。 IC50 & Target:CPT-1 相关产品:Etomoxir | Etomoxir (Standard) | Etomoxir sodium salt | Diphenyl Phosphate | Perhexiline maleate | Teglicar | Baicalin | Baicalin (Standard) | Perhexiline maleate (Standard) | DGAT-1 inhibitor 2 | Isorhapontigenin | 4-Hydroxyphenylglyoxylate 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 参考文献: 品牌介绍:
| |||||||